Fluorine in PDB 8h3k: Crystal Structure of Sars-Cov-2 Main Protease (Mpro) Double Mutant (L50F and E166V) in Complex with Inhibitor Enstrelvir
Enzymatic activity of Crystal Structure of Sars-Cov-2 Main Protease (Mpro) Double Mutant (L50F and E166V) in Complex with Inhibitor Enstrelvir
All present enzymatic activity of Crystal Structure of Sars-Cov-2 Main Protease (Mpro) Double Mutant (L50F and E166V) in Complex with Inhibitor Enstrelvir:
3.4.22.69;
Protein crystallography data
The structure of Crystal Structure of Sars-Cov-2 Main Protease (Mpro) Double Mutant (L50F and E166V) in Complex with Inhibitor Enstrelvir, PDB code: 8h3k
was solved by
H.Wang,
M.Lin,
Y.Duan,
X.Zhang,
H.Zhou,
Q.Bian,
X.Liu,
Z.Rao,
H.Yang,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
52.83 /
1.80
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
55.543,
98.875,
58.991,
90,
108,
90
|
R / Rfree (%)
|
16.8 /
20.1
|
Other elements in 8h3k:
The structure of Crystal Structure of Sars-Cov-2 Main Protease (Mpro) Double Mutant (L50F and E166V) in Complex with Inhibitor Enstrelvir also contains other interesting chemical elements:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Crystal Structure of Sars-Cov-2 Main Protease (Mpro) Double Mutant (L50F and E166V) in Complex with Inhibitor Enstrelvir
(pdb code 8h3k). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 6 binding sites of Fluorine where determined in the
Crystal Structure of Sars-Cov-2 Main Protease (Mpro) Double Mutant (L50F and E166V) in Complex with Inhibitor Enstrelvir, PDB code: 8h3k:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
Fluorine binding site 1 out
of 6 in 8h3k
Go back to
Fluorine Binding Sites List in 8h3k
Fluorine binding site 1 out
of 6 in the Crystal Structure of Sars-Cov-2 Main Protease (Mpro) Double Mutant (L50F and E166V) in Complex with Inhibitor Enstrelvir
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Crystal Structure of Sars-Cov-2 Main Protease (Mpro) Double Mutant (L50F and E166V) in Complex with Inhibitor Enstrelvir within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F401
b:30.3
occ:1.00
|
F28
|
A:7YY401
|
0.0
|
30.3
|
1.0
|
C27
|
A:7YY401
|
1.4
|
28.0
|
1.0
|
C26
|
A:7YY401
|
2.4
|
26.5
|
1.0
|
C29
|
A:7YY401
|
2.4
|
24.1
|
1.0
|
C25
|
A:7YY401
|
2.8
|
27.9
|
1.0
|
O
|
A:HOH601
|
3.2
|
27.2
|
1.0
|
CA
|
A:GLN189
|
3.2
|
28.2
|
1.0
|
CB
|
A:GLN189
|
3.3
|
26.7
|
1.0
|
CG
|
A:GLN189
|
3.3
|
30.1
|
1.0
|
O
|
A:HOH661
|
3.4
|
27.8
|
0.8
|
O
|
A:HOH604
|
3.6
|
27.9
|
1.0
|
C34
|
A:7YY401
|
3.6
|
25.5
|
1.0
|
C30
|
A:7YY401
|
3.6
|
28.1
|
1.0
|
NE2
|
A:GLN189
|
3.7
|
37.5
|
1.0
|
CD
|
A:GLN189
|
3.8
|
32.8
|
1.0
|
O
|
A:HOH676
|
3.8
|
35.6
|
1.0
|
N
|
A:GLN189
|
3.8
|
28.0
|
1.0
|
O
|
A:ARG188
|
4.1
|
26.8
|
1.0
|
C32
|
A:7YY401
|
4.1
|
23.2
|
1.0
|
C
|
A:ARG188
|
4.2
|
28.5
|
1.0
|
N24
|
A:7YY401
|
4.2
|
26.2
|
1.0
|
CB
|
A:MET165
|
4.4
|
26.5
|
1.0
|
C
|
A:GLN189
|
4.5
|
29.8
|
1.0
|
NE2
|
A:HIS41
|
4.5
|
27.6
|
1.0
|
OE1
|
A:GLN189
|
4.7
|
37.6
|
1.0
|
O36
|
A:7YY401
|
4.7
|
23.9
|
1.0
|
F31
|
A:7YY401
|
4.8
|
26.8
|
1.0
|
SD
|
A:MET165
|
4.8
|
30.4
|
1.0
|
N
|
A:THR190
|
4.9
|
30.1
|
1.0
|
N12
|
A:7YY401
|
4.9
|
22.3
|
1.0
|
C35
|
A:7YY401
|
4.9
|
24.1
|
1.0
|
CE1
|
A:HIS41
|
5.0
|
29.7
|
1.0
|
|
Fluorine binding site 2 out
of 6 in 8h3k
Go back to
Fluorine Binding Sites List in 8h3k
Fluorine binding site 2 out
of 6 in the Crystal Structure of Sars-Cov-2 Main Protease (Mpro) Double Mutant (L50F and E166V) in Complex with Inhibitor Enstrelvir
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Crystal Structure of Sars-Cov-2 Main Protease (Mpro) Double Mutant (L50F and E166V) in Complex with Inhibitor Enstrelvir within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F401
b:26.8
occ:1.00
|
F31
|
A:7YY401
|
0.0
|
26.8
|
1.0
|
C30
|
A:7YY401
|
1.4
|
28.1
|
1.0
|
C32
|
A:7YY401
|
2.4
|
23.2
|
1.0
|
C29
|
A:7YY401
|
2.4
|
24.1
|
1.0
|
F33
|
A:7YY401
|
2.7
|
23.5
|
1.0
|
CB
|
A:ASP187
|
3.0
|
21.9
|
1.0
|
CA
|
A:ASP187
|
3.0
|
23.4
|
1.0
|
C
|
A:ASP187
|
3.2
|
28.2
|
1.0
|
ND1
|
A:HIS41
|
3.5
|
25.6
|
1.0
|
N
|
A:ARG188
|
3.6
|
28.1
|
1.0
|
C27
|
A:7YY401
|
3.6
|
28.0
|
1.0
|
C34
|
A:7YY401
|
3.6
|
25.5
|
1.0
|
O
|
A:ASP187
|
3.6
|
27.7
|
1.0
|
CG
|
A:HIS41
|
3.7
|
22.5
|
1.0
|
CE1
|
A:HIS41
|
3.8
|
29.7
|
1.0
|
SD
|
A:MET165
|
4.0
|
30.4
|
1.0
|
C26
|
A:7YY401
|
4.1
|
26.5
|
1.0
|
CB
|
A:HIS41
|
4.1
|
19.9
|
1.0
|
CD2
|
A:HIS41
|
4.2
|
25.4
|
1.0
|
O
|
A:HOH630
|
4.2
|
20.9
|
1.0
|
OH
|
A:TYR54
|
4.3
|
27.1
|
1.0
|
NE2
|
A:HIS41
|
4.3
|
27.6
|
1.0
|
CG
|
A:ASP187
|
4.4
|
22.6
|
1.0
|
CA
|
A:ARG188
|
4.4
|
26.7
|
1.0
|
N
|
A:ASP187
|
4.4
|
21.7
|
1.0
|
ND1
|
A:HIS164
|
4.5
|
21.9
|
1.0
|
C
|
A:ARG188
|
4.6
|
28.5
|
1.0
|
CB
|
A:HIS164
|
4.7
|
17.6
|
1.0
|
O
|
A:VAL186
|
4.7
|
26.3
|
1.0
|
O
|
A:ARG188
|
4.7
|
26.8
|
1.0
|
F28
|
A:7YY401
|
4.8
|
30.3
|
1.0
|
OD2
|
A:ASP187
|
4.8
|
20.2
|
1.0
|
CB
|
A:MET165
|
4.9
|
26.5
|
1.0
|
|
Fluorine binding site 3 out
of 6 in 8h3k
Go back to
Fluorine Binding Sites List in 8h3k
Fluorine binding site 3 out
of 6 in the Crystal Structure of Sars-Cov-2 Main Protease (Mpro) Double Mutant (L50F and E166V) in Complex with Inhibitor Enstrelvir
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Crystal Structure of Sars-Cov-2 Main Protease (Mpro) Double Mutant (L50F and E166V) in Complex with Inhibitor Enstrelvir within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F401
b:23.5
occ:1.00
|
F33
|
A:7YY401
|
0.0
|
23.5
|
1.0
|
C32
|
A:7YY401
|
1.4
|
23.2
|
1.0
|
C30
|
A:7YY401
|
2.4
|
28.1
|
1.0
|
C34
|
A:7YY401
|
2.4
|
25.5
|
1.0
|
F31
|
A:7YY401
|
2.7
|
26.8
|
1.0
|
O
|
A:HIS164
|
3.3
|
23.2
|
1.0
|
CB
|
A:HIS41
|
3.4
|
19.9
|
1.0
|
SG
|
A:CYS145
|
3.4
|
22.8
|
1.0
|
CG
|
A:HIS41
|
3.5
|
22.5
|
1.0
|
C29
|
A:7YY401
|
3.6
|
24.1
|
1.0
|
C26
|
A:7YY401
|
3.6
|
26.5
|
1.0
|
CB
|
A:HIS164
|
3.7
|
17.6
|
1.0
|
CD2
|
A:HIS41
|
3.7
|
25.4
|
1.0
|
C
|
A:HIS164
|
3.8
|
18.2
|
1.0
|
ND1
|
A:HIS164
|
3.8
|
21.9
|
1.0
|
CA
|
A:HIS164
|
3.9
|
17.8
|
1.0
|
O
|
A:HOH630
|
4.1
|
20.9
|
1.0
|
C27
|
A:7YY401
|
4.1
|
28.0
|
1.0
|
CG
|
A:HIS164
|
4.1
|
20.4
|
1.0
|
ND1
|
A:HIS41
|
4.2
|
25.6
|
1.0
|
CL2
|
A:7YY401
|
4.4
|
24.5
|
1.0
|
NE2
|
A:HIS41
|
4.5
|
27.6
|
1.0
|
CB
|
A:PRO39
|
4.7
|
18.7
|
1.0
|
N
|
A:MET165
|
4.7
|
19.4
|
1.0
|
CE1
|
A:HIS41
|
4.8
|
29.7
|
1.0
|
CB
|
A:MET165
|
4.8
|
26.5
|
1.0
|
CA
|
A:HIS41
|
4.9
|
21.0
|
1.0
|
CB
|
A:ASP187
|
4.9
|
21.9
|
1.0
|
C25
|
A:7YY401
|
4.9
|
27.9
|
1.0
|
CE1
|
A:HIS164
|
4.9
|
21.0
|
1.0
|
CB
|
A:CYS145
|
5.0
|
19.6
|
1.0
|
|
Fluorine binding site 4 out
of 6 in 8h3k
Go back to
Fluorine Binding Sites List in 8h3k
Fluorine binding site 4 out
of 6 in the Crystal Structure of Sars-Cov-2 Main Protease (Mpro) Double Mutant (L50F and E166V) in Complex with Inhibitor Enstrelvir
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Crystal Structure of Sars-Cov-2 Main Protease (Mpro) Double Mutant (L50F and E166V) in Complex with Inhibitor Enstrelvir within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F401
b:29.5
occ:1.00
|
F28
|
B:7YY401
|
0.0
|
29.5
|
1.0
|
C27
|
B:7YY401
|
1.4
|
33.7
|
1.0
|
C26
|
B:7YY401
|
2.3
|
24.9
|
1.0
|
C29
|
B:7YY401
|
2.4
|
30.8
|
1.0
|
C25
|
B:7YY401
|
2.7
|
23.8
|
1.0
|
O
|
B:HOH603
|
3.1
|
32.0
|
1.0
|
CA
|
B:GLN189
|
3.1
|
32.0
|
1.0
|
CB
|
B:GLN189
|
3.2
|
33.9
|
1.0
|
CG
|
B:GLN189
|
3.3
|
38.4
|
1.0
|
O
|
B:HOH629
|
3.4
|
35.0
|
1.0
|
NE2
|
B:GLN189
|
3.5
|
47.5
|
1.0
|
C30
|
B:7YY401
|
3.6
|
31.0
|
1.0
|
O
|
B:HOH591
|
3.6
|
28.7
|
1.0
|
C34
|
B:7YY401
|
3.6
|
31.2
|
1.0
|
O
|
B:HOH669
|
3.8
|
43.3
|
1.0
|
CD
|
B:GLN189
|
3.8
|
41.9
|
1.0
|
N
|
B:GLN189
|
3.8
|
31.4
|
1.0
|
O
|
B:ARG188
|
3.9
|
30.1
|
1.0
|
C32
|
B:7YY401
|
4.1
|
29.6
|
1.0
|
N24
|
B:7YY401
|
4.2
|
31.5
|
1.0
|
C
|
B:ARG188
|
4.2
|
30.9
|
1.0
|
C
|
B:GLN189
|
4.3
|
41.1
|
1.0
|
CB
|
B:MET165
|
4.4
|
34.3
|
1.0
|
O36
|
B:7YY401
|
4.5
|
27.1
|
1.0
|
NE2
|
B:HIS41
|
4.7
|
30.9
|
1.0
|
N
|
B:THR190
|
4.7
|
44.7
|
1.0
|
F31
|
B:7YY401
|
4.7
|
35.5
|
1.0
|
SD
|
B:MET165
|
4.8
|
33.0
|
1.0
|
OE1
|
B:GLN189
|
4.8
|
43.6
|
1.0
|
C35
|
B:7YY401
|
4.9
|
27.9
|
1.0
|
CE1
|
B:HIS41
|
4.9
|
29.0
|
1.0
|
N12
|
B:7YY401
|
5.0
|
29.5
|
1.0
|
|
Fluorine binding site 5 out
of 6 in 8h3k
Go back to
Fluorine Binding Sites List in 8h3k
Fluorine binding site 5 out
of 6 in the Crystal Structure of Sars-Cov-2 Main Protease (Mpro) Double Mutant (L50F and E166V) in Complex with Inhibitor Enstrelvir
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Crystal Structure of Sars-Cov-2 Main Protease (Mpro) Double Mutant (L50F and E166V) in Complex with Inhibitor Enstrelvir within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F401
b:35.5
occ:1.00
|
F31
|
B:7YY401
|
0.0
|
35.5
|
1.0
|
C30
|
B:7YY401
|
1.4
|
31.0
|
1.0
|
C32
|
B:7YY401
|
2.4
|
29.6
|
1.0
|
C29
|
B:7YY401
|
2.4
|
30.8
|
1.0
|
F33
|
B:7YY401
|
2.7
|
27.1
|
1.0
|
CB
|
B:ASP187
|
3.0
|
26.4
|
1.0
|
CA
|
B:ASP187
|
3.0
|
28.7
|
1.0
|
C
|
B:ASP187
|
3.3
|
33.6
|
1.0
|
ND1
|
B:HIS41
|
3.4
|
27.5
|
1.0
|
C27
|
B:7YY401
|
3.6
|
33.7
|
1.0
|
O
|
B:ASP187
|
3.6
|
32.5
|
1.0
|
C34
|
B:7YY401
|
3.6
|
31.2
|
1.0
|
CG
|
B:HIS41
|
3.7
|
28.3
|
1.0
|
N
|
B:ARG188
|
3.8
|
29.4
|
1.0
|
CE1
|
B:HIS41
|
3.8
|
29.0
|
1.0
|
SD
|
B:MET165
|
4.0
|
33.0
|
1.0
|
C26
|
B:7YY401
|
4.1
|
24.9
|
1.0
|
CB
|
B:HIS41
|
4.1
|
25.8
|
1.0
|
O
|
B:HOH601
|
4.2
|
19.8
|
0.9
|
CD2
|
B:HIS41
|
4.3
|
31.1
|
1.0
|
NE2
|
B:HIS41
|
4.3
|
30.9
|
1.0
|
CG
|
B:ASP187
|
4.4
|
26.1
|
1.0
|
N
|
B:ASP187
|
4.4
|
23.7
|
1.0
|
OH
|
B:TYR54
|
4.5
|
27.6
|
1.0
|
CD2
|
B:HIS164
|
4.6
|
20.6
|
1.0
|
C
|
B:ARG188
|
4.6
|
30.9
|
1.0
|
CA
|
B:ARG188
|
4.6
|
37.8
|
1.0
|
O
|
B:ARG188
|
4.6
|
30.1
|
1.0
|
F28
|
B:7YY401
|
4.7
|
29.5
|
1.0
|
CB
|
B:HIS164
|
4.7
|
22.1
|
1.0
|
CB
|
B:MET165
|
4.7
|
34.3
|
1.0
|
O
|
B:VAL186
|
4.8
|
25.9
|
1.0
|
CG
|
B:MET165
|
4.9
|
30.5
|
1.0
|
OD2
|
B:ASP187
|
4.9
|
27.2
|
1.0
|
|
Fluorine binding site 6 out
of 6 in 8h3k
Go back to
Fluorine Binding Sites List in 8h3k
Fluorine binding site 6 out
of 6 in the Crystal Structure of Sars-Cov-2 Main Protease (Mpro) Double Mutant (L50F and E166V) in Complex with Inhibitor Enstrelvir
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of Crystal Structure of Sars-Cov-2 Main Protease (Mpro) Double Mutant (L50F and E166V) in Complex with Inhibitor Enstrelvir within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F401
b:27.1
occ:1.00
|
F33
|
B:7YY401
|
0.0
|
27.1
|
1.0
|
C32
|
B:7YY401
|
1.4
|
29.6
|
1.0
|
C30
|
B:7YY401
|
2.4
|
31.0
|
1.0
|
C34
|
B:7YY401
|
2.4
|
31.2
|
1.0
|
F31
|
B:7YY401
|
2.7
|
35.5
|
1.0
|
O
|
B:HIS164
|
3.3
|
27.8
|
1.0
|
CB
|
B:HIS41
|
3.3
|
25.8
|
1.0
|
CG
|
B:HIS41
|
3.4
|
28.3
|
1.0
|
SG
|
B:CYS145
|
3.4
|
23.9
|
1.0
|
CD2
|
B:HIS41
|
3.6
|
31.1
|
1.0
|
C29
|
B:7YY401
|
3.6
|
30.8
|
1.0
|
C26
|
B:7YY401
|
3.6
|
24.9
|
1.0
|
C
|
B:HIS164
|
3.8
|
25.2
|
1.0
|
CB
|
B:HIS164
|
3.9
|
22.1
|
1.0
|
CD2
|
B:HIS164
|
3.9
|
20.6
|
1.0
|
CA
|
B:HIS164
|
4.0
|
20.7
|
1.0
|
ND1
|
B:HIS41
|
4.1
|
27.5
|
1.0
|
C27
|
B:7YY401
|
4.1
|
33.7
|
1.0
|
O
|
B:HOH601
|
4.2
|
19.8
|
0.9
|
CG
|
B:HIS164
|
4.2
|
25.7
|
1.0
|
CL2
|
B:7YY401
|
4.3
|
26.9
|
1.0
|
NE2
|
B:HIS41
|
4.4
|
30.9
|
1.0
|
CE1
|
B:HIS41
|
4.6
|
29.0
|
1.0
|
CB
|
B:MET165
|
4.7
|
34.3
|
1.0
|
CB
|
B:PRO39
|
4.7
|
19.8
|
1.0
|
CA
|
B:HIS41
|
4.8
|
22.0
|
1.0
|
N
|
B:MET165
|
4.9
|
24.3
|
1.0
|
CB
|
B:ASP187
|
4.9
|
26.4
|
1.0
|
C25
|
B:7YY401
|
4.9
|
23.8
|
1.0
|
CB
|
B:CYS145
|
5.0
|
24.8
|
1.0
|
N24
|
B:7YY401
|
5.0
|
31.5
|
1.0
|
|
Reference:
Y.Duan,
H.Zhou,
X.Liu,
S.Iketani,
M.Lin,
X.Zhang,
Q.Bian,
H.Wang,
H.Sun,
S.J.Hong,
B.Culbertson,
H.Mohri,
M.I.Luck,
Y.Zhu,
X.Liu,
Y.Lu,
X.Yang,
K.Yang,
Y.Sabo,
A.Chavez,
S.P.Goff,
Z.Rao,
D.D.Ho,
H.Yang.
Molecular Mechanisms of Sars-Cov-2 Resistance to Nirmatrelvir. Nature 2023.
ISSN: ESSN 1476-4687
PubMed: 37696289
DOI: 10.1038/S41586-023-06609-0
Page generated: Fri Aug 2 20:00:10 2024
|